Oncolytics Biotech Inc
(ONCY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 20,052 | 21,581 | 22,794 | 10,662 | 9,318 |
| Receivables | 53 | 41 | 95 | 1,559 | 347 |
| TOTAL | $22,909 | $24,588 | $25,283 | $14,266 | $11,696 |
| Non-Current Assets | |||||
| PPE Net | 196 | 194 | 216 | 224 | 244 |
| Other Non-Current Assets | 348 | 186 | 266 | 325 | 398 |
| TOTAL | $544 | $380 | $483 | $548 | $642 |
| Total Assets | $23,453 | $24,967 | $25,766 | $14,814 | $12,338 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,711 | 1,939 | 2,072 | 2,391 | 2,822 |
| Other current liabilities | 560 | 630 | 876 | 7,051 | N/A |
| TOTAL | $2,520 | $2,790 | $3,204 | $9,698 | $3,094 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 5,191 | 4,869 | 5,088 | 5,197 | 6,629 |
| TOTAL | $5,191 | $4,869 | $5,088 | $5,197 | $6,629 |
| Total Liabilities | $7,710 | $7,659 | $8,293 | $14,896 | $9,723 |
| Shareholders' Equity | |||||
| Common Shares | 258,854 | 246,140 | 248,907 | 234,428 | 223,913 |
| Retained earnings | -268,587 | -253,271 | -256,675 | -259,695 | -246,375 |
| Other shareholders' equity | 3,125 | 3,052 | 3,264 | 3,076 | 3,135 |
| TOTAL | $15,743 | $17,308 | $17,473 | $-81 | $2,615 |
| Total Liabilities And Equity | $23,453 | $24,967 | $25,766 | $14,814 | $12,338 |